FMR LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 315066 BOSTON, MA

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,719,769

-$33,822,921 QoQ

Shares Held

1,244,137

-52.9% QoQ

Ownership

1.32%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 98.45451103857533.ToString("F0")% Shared 0.ToString("F0")% None 1.5454889614246663.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,674,888,413 across 352 Biotechnology names. FTRE ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,719,769	1,244,137	-52.9%	Shares	Defined	2026-05-15
2025-12-31	$45,542,690	2,640,156	-13.5%	Shares	Defined	2026-02-17
2025-09-30	$25,701,931	3,052,486	-0.6%	Shares	Defined	2025-11-13
2025-06-30	$15,171,148	3,071,083	-41.5%	Shares	Defined	2025-08-14
2025-03-31	$39,657,432	5,252,640	-35.0%	Shares	Defined	2025-05-12
2024-12-31	$150,818,930	8,086,806	+67.7%	Shares	Defined	2025-02-13
2024-09-30	$96,428,080	4,821,404	+91.6%	Shares	Defined	2024-11-13
2024-06-30	$58,740,406	2,516,727	+165.0%	Shares	Defined	2024-08-13
2024-03-31	$38,127,218	949,856	+285.8%	Shares	Defined	2024-05-13
2023-12-31	$8,592,344	246,199	-76.6%	Shares	Defined	2024-02-13
2023-09-30	$30,122,508	1,053,603	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.